VRCA
Verrica Pharmaceuticals Inc.
Company overview
- Market capitalization
- $79.02M
- Employees
- 76
- Latest publication
- 2026-09-29
About Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,862,000USD | 5,023,000USD | 5,092,000USD | 14,344,000USD | 12,702,000USD | 3,439,000USD | 344,000USD | -1,781,000USD |
| Research Development | 6,034,000USD | 3,860,000USD | 2,520,000USD | 2,205,000USD | 1,846,000USD | 2,284,000USD | 1,167,000USD | 2,405,000USD |
| Selling General Administrative | 10,349,000USD | 9,989,000USD | 8,548,000USD | 9,403,000USD | 8,852,000USD | 8,548,000USD | 6,183,300USD | 14,982,999USD |
| Total Operating Expenses | 18,959,000USD | 13,849,000USD | 10,637,000USD | 11,608,000USD | 10,698,000USD | 11,146,000USD | 11,129,000USD | 18,488,000USD |
| Operating Income | -13,097,000USD | -9,715,000USD | -6,946,000USD | 1,627,000USD | 1,510,000USD | -8,130,000USD | -11,410,000USD | -20,704,000USD |
| Total Other Income Expense Net | -56,000USD | 33,000USD | -1,128,000USD | -1,901,000USD | -1,306,000USD | -1,612,000USD | -4,792,000USD | -2,156,000USD |
| Interest Income | 111,000USD | 201,000USD | 205,000USD | 159,000USD | 228,000USD | 337,000USD | 205,000USD | 221,000USD |
| Interest Expense | 164,000USD | 160,000USD | 1,314,000USD | 2,094,000USD | 2,131,000USD | 2,203,000USD | 2,349,000USD | 2,376,000USD |
| Net Income | -13,153,000USD | -9,682,000USD | -8,074,000USD | -274,000USD | 204,000USD | -9,742,000USD | -16,202,000USD | -22,860,000USD |
| Cost Of Revenue | — | 889,000USD | 1,401,000USD | 1,109,000USD | 494,000USD | 423,000USD | 625,000USD | 435,000USD |
| Gross Profit | — | 4,134,000USD | 3,691,000USD | 13,235,000USD | 12,208,000USD | 3,016,000USD | -281,000USD | -2,216,000USD |
| Net Interest Income | — | 41,000USD | -1,109,000USD | -1,935,000USD | -1,903,000USD | -1,866,000USD | -2,144,000USD | -2,155,000USD |
| Income Before Tax | — | -9,682,000USD | -8,074,000USD | -274,000USD | 204,000USD | -9,742,000USD | -16,202,000USD | -22,860,000USD |
| Net Income From Continuing Ops | — | -9,682,000USD | -8,074,000USD | -274,000USD | 204,000USD | -9,742,000USD | -16,202,000USD | -22,860,000USD |
| Ebit | — | -9,715,000USD | -6,760,000USD | 1,820,000USD | 2,335,000USD | -7,539,000USD | -13,853,000USD | -20,484,000USD |
| Ebitda | — | -9,521,000USD | -6,570,000USD | 2,004,000USD | 2,534,000USD | -7,331,000USD | -13,600,000USD | -20,142,000USD |
| Depreciation And Amortization | — | 194,000USD | 190,000USD | 184,000USD | 199,000USD | 208,000USD | 253,000USD | 342,000USD |
| Reconciled Depreciation | — | 194,000USD | 190,000USD | 184,000USD | 199,000USD | 208,000USD | 253,000USD | 342,000USD |
| Selling And Marketing Expenses | — | — | 300,000USD | — | — | 300,000USD | 3,695,700USD | 1,100,000USD |
| Income Tax Expense | — | — | — | — | — | — | -296,724USD | -342,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 35,577,000USD | 7,566,000USD | 5,124,000USD | 9,032,000USD | 12,000,000USD | 12,000,000USD | 0USD | 0USD |
| Cost Of Revenue | 3,441,000USD | 2,740,000USD | 746,000USD | 725,000USD | 472,000USD | 229,000USD | 257,199USD | 20,294USD |
| Gross Profit | 32,136,000USD | 4,826,000USD | 4,378,000USD | 8,307,000USD | 11,528,000USD | -229,000USD | -257,199USD | -20,294USD |
| Research Development | 8,855,000USD | 11,840,000USD | 20,295,000USD | 12,198,000USD | 15,929,000USD | 15,673,000USD | 15,436,000USD | 12,826,000USD |
| Selling General Administrative | 35,220,000USD | 58,017,700USD | 47,301,500USD | 17,405,000USD | 26,979,000USD | 24,508,000USD | 14,644,000USD | 9,052,000USD |
| Total Operating Expenses | 44,075,000USD | 70,745,000USD | 70,137,000USD | 29,603,000USD | 42,436,000USD | 39,952,000USD | 30,080,000USD | 21,878,000USD |
| Operating Income | -11,939,000USD | -65,919,000USD | -65,759,000USD | -21,296,000USD | -30,908,000USD | -40,181,000USD | -30,080,000USD | -21,878,000USD |
| Interest Income | 929,000USD | 1,417,000USD | 2,234,000USD | 476,000USD | 123,000USD | 521,000USD | 1,877,000USD | 1,231,000USD |
| Interest Expense | 7,742,000USD | 9,412,000USD | 3,962,000USD | 2,172,000USD | 4,295,000USD | 3,033,000USD | 0USD | 0USD |
| Net Interest Income | -6,813,000USD | -7,995,000USD | 577,000USD | -1,696,000USD | -4,172,000USD | -2,512,000USD | 1,877,000USD | 1,231,000USD |
| Income Before Tax | -17,886,000USD | -76,579,000USD | -66,995,000USD | -24,487,000USD | -35,080,000USD | -42,694,000USD | -28,207,000USD | -20,648,000USD |
| Net Income | -17,886,000USD | -76,579,000USD | -66,995,000USD | -24,487,000USD | -35,080,000USD | -45,497,000USD | -27,950,000USD | -20,648,000USD |
| Net Income From Continuing Ops | -17,886,000USD | -76,579,000USD | -48,313,000USD | -24,487,000USD | -35,080,000USD | -42,694,000USD | -28,207,000USD | -20,648,000USD |
| Ebit | -10,144,000USD | -67,167,000USD | -63,033,000USD | -22,315,000USD | -30,785,000USD | -39,661,000USD | -30,080,000USD | -20,648,000USD |
| Ebitda | -9,363,000USD | -65,898,000USD | -62,197,000USD | -21,597,000USD | -30,313,000USD | -39,432,000USD | -29,823,000USD | -20,627,706USD |
| Depreciation And Amortization | 781,000USD | 1,269,000USD | 836,000USD | 718,000USD | 472,000USD | 229,000USD | 257,000USD | 20,294USD |
| Reconciled Depreciation | 781,000USD | 1,269,000USD | 820,000USD | 718,000USD | 472,000USD | 229,000USD | 257,000USD | 20,000USD |
| Total Other Income Expense Net | -5,947,000USD | -10,660,000USD | -1,236,000USD | -3,191,000USD | -4,172,000USD | -2,513,000USD | 1,873,000USD | 1,230,000USD |
| Selling And Marketing Expenses | — | 4,300USD | 3,500USD | — | — | — | — | — |
| Unclassified Operating Expenses | — | — | 2,537,000USD | — | — | — | — | — |
| Income Tax Expense | — | — | 668,105USD | 3,191,000USD | 3,823,000USD | 2,803,000USD | -257,000USD | 1,230,000USD |
| Non Operating Income Net Other | — | — | — | -1,019,000USD | 123,000USD | 520,000USD | 1,873,000USD | 1,230,000USD |
| Net Income Applicable To Common Shares | — | — | — | -24,487,000USD | -35,080,000USD | -42,694,000USD | -28,207,000USD | -20,648,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 36,017,000USD | 38,786,000USD | 47,131,000USD | 40,896,000USD | 39,107,000USD | 42,178,000USD | 54,134,000USD | 32,927,000USD |
| Cash And Equivalents | 11,198,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 32,639,000USD | 32,755,000USD | 42,539,000USD | 36,275,000USD | 36,781,000USD | 39,474,000USD | 51,179,000USD | 28,187,000USD |
| Other Current Assets | 2,619,000USD | 2,368,000USD | 4,759,000USD | 5,545,000USD | 1,492,000USD | 1,767,000USD | 2,310,000USD | 2,560,000USD |
| Other Non Current Assets | 638,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 31,710,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 22,442,000USD | 16,219,000USD | 16,437,000USD | 28,908,000USD | 29,222,000USD | 29,396,000USD | 29,012,000USD | 21,026,000USD |
| Total Stockholder Equity | 4,307,000USD | 16,055,000USD | 24,743,000USD | -17,040,000USD | -17,484,000USD | -18,576,000USD | -9,860,000USD | -34,051,000USD |
| Total Equity Including Noncontrolling Interest | 4,307,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 1,335,000USD | — | — | — | — | — | — | — |
| Net Receivables | 10,939,000USD | 7,813,000USD | 5,397,000USD | 7,329,000USD | 17,371,000USD | 5,653,000USD | 77,000USD | 84,000USD |
| Inventory | 2,712,000USD | 1,974,000USD | 2,236,000USD | 2,304,000USD | 2,522,000USD | 2,459,000USD | 2,463,000USD | 2,584,000USD |
| Property Plant Equipment Net | 561,000USD | 1,663,000USD | 1,862,000USD | 1,891,000USD | 1,950,000USD | 2,328,000USD | 2,579,000USD | 4,202,000USD |
| Accounts Payable | 1,603,000USD | 2,193,000USD | 2,072,000USD | 1,585,000USD | 2,321,000USD | 1,443,000USD | 1,896,000USD | 966,000USD |
| Short Term Debt | 355,000USD | 744,000USD | 746,000USD | 13,159,000USD | 13,319,000USD | 13,469,000USD | 13,605,000USD | 1,161,000USD |
| Common Stock | 2,000USD | 2,000USD | 2,000USD | 1,000USD | 1,000USD | 9,000USD | 9,000USD | 5,000USD |
| Retained Earnings | -347,748,000USD | -334,595,000USD | -324,913,000USD | -316,839,000USD | -316,565,000USD | -316,769,000USD | -307,027,000USD | -290,825,000USD |
| Total Liab | — | 22,731,000USD | 22,388,000USD | 57,936,000USD | 56,591,000USD | 60,754,000USD | 63,994,000USD | 66,978,000USD |
| Other Current Liab | — | 12,251,000USD | 12,837,000USD | 12,600,000USD | 13,101,000USD | 14,484,000USD | 13,511,000USD | 18,899,000USD |
| Capital Stock | — | 2,000USD | 2,000USD | 1,000USD | 1,000USD | 9,000USD | 9,000USD | 5,000USD |
| Other Assets | — | 1USD | — | — | — | — | -483,000USD | — |
| Cash | — | 20,600,000USD | 30,147,000USD | 21,097,000USD | 15,396,000USD | 29,595,000USD | 46,329,000USD | 22,959,000USD |
| Cash And Short Term Investments | — | 20,600,000USD | 30,147,000USD | 21,097,000USD | 15,396,000USD | 29,595,000USD | 46,329,000USD | 22,959,000USD |
| Current Deferred Revenue | — | 1,030,999USD | 782,000USD | 1,564,000USD | 481,000USD | — | — | — |
| Net Debt | — | -19,158,000USD | -28,516,000USD | 14,640,000USD | 23,496,000USD | 12,838,000USD | -390,000USD | 24,154,000USD |
| Short Long Term Debt Total | — | 1,442,000USD | 1,631,000USD | 35,737,000USD | 38,892,000USD | 42,433,000USD | 45,939,000USD | 47,113,000USD |
| Property Plant Equipment Gross | — | 1,663,000USD | 2,912,000USD | 2,925,000USD | 3,055,000USD | 3,638,000USD | 3,837,000USD | 5,467,000USD |
| Common Stock Shares Outstanding | — | 10,652,367shares | 10,652,367shares | 9,490,083shares | 9,490,600shares | 9,483,734shares | 6,732,599shares | 4,680,542shares |
| Non Current Assets Total | — | 6,030,999USD | 4,592,000USD | 4,621,000USD | 2,326,000USD | 2,704,000USD | 2,955,000USD | 4,740,000USD |
| Non Current Liabilities Total | — | 6,512,000USD | 5,951,000USD | 29,028,000USD | 27,369,000USD | 31,358,000USD | 34,982,000USD | 45,952,000USD |
| Non Current Liabilities Other | — | 5,814,000USD | 5,066,000USD | 4,688,000USD | — | — | — | — |
| Non Currrent Assets Other | — | 4,103,999USD | 2,730,000USD | 2,730,000USD | 376,000USD | 376,000USD | 376,000USD | 538,000USD |
| Net Working Capital | — | 17,910,000USD | 26,102,000USD | 7,367,000USD | 7,559,000USD | 10,078,000USD | 22,167,000USD | 7,161,000USD |
| Unclassified Equity | — | 350,646,000USD | 349,652,000USD | 299,797,000USD | 299,079,000USD | 298,175,000USD | 297,149,000USD | 256,764,000USD |
| Short Long Term Debt | — | — | — | 12,458,000USD | 12,673,000USD | 12,821,000USD | 12,938,000USD | — |
| Long Term Debt | — | — | — | 21,619,000USD | 24,578,000USD | 27,809,000USD | 30,983,000USD | 43,305,000USD |
| Unclassified Current Liabilities | — | — | — | -12,458,000USD | -12,673,000USD | -12,821,000USD | -12,938,000USD | — |
| Unclassified Non Current Liabilities | — | — | — | 2,721,000USD | 2,791,000USD | 3,549,000USD | 3,999,000USD | 2,647,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 47,131,000USD | 54,134,000USD | 81,597,000USD | 44,721,000USD | 80,125,000USD | 74,154,000USD | 68,424,000USD | 91,906,000USD |
| Other Current Assets | 4,759,000USD | 2,310,000USD | 2,545,000USD | 4,355,000USD | 3,974,000USD | 2,180,000USD | 2,966,000USD | 1,343,000USD |
| Total Liab | 22,388,000USD | 63,994,000USD | 61,834,000USD | 4,688,000USD | 47,520,000USD | 41,168,000USD | 3,409,000USD | 2,477,000USD |
| Total Stockholder Equity | 24,743,000USD | -9,860,000USD | 19,763,000USD | 40,033,000USD | 32,605,000USD | 32,986,000USD | 65,015,000USD | 89,429,000USD |
| Other Current Liab | 12,837,000USD | 13,511,000USD | 13,860,000USD | 2,655,000USD | 3,266,000USD | 3,114,000USD | 2,036,000USD | 1,517,000USD |
| Common Stock | 2,000USD | 9,000USD | 4,000USD | 4,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD |
| Capital Stock | 2,000USD | 9,000USD | 4,000USD | 4,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD |
| Retained Earnings | -324,913,000USD | -307,027,000USD | -230,448,000USD | -163,453,000USD | -138,966,000USD | -103,886,000USD | -61,192,000USD | -33,083,000USD |
| Cash | 30,147,000USD | 46,329,000USD | 69,547,000USD | 34,273,000USD | 15,752,000USD | 10,686,000USD | 9,241,000USD | 10,271,000USD |
| Cash And Short Term Investments | 30,147,000USD | 46,329,000USD | 69,547,000USD | 34,273,000USD | 70,354,000USD | 65,470,000USD | 62,017,000USD | 89,809,000USD |
| Total Current Assets | 42,539,000USD | 51,179,000USD | 77,530,000USD | 39,115,000USD | 74,328,000USD | 67,650,000USD | 64,983,000USD | 91,152,000USD |
| Total Current Liabilities | 16,437,000USD | 29,012,000USD | 17,024,000USD | 3,459,000USD | 46,055,000USD | 39,475,000USD | 3,351,000USD | 2,477,000USD |
| Current Deferred Revenue | 782,000USD | — | — | — | — | 500,000USD | — | — |
| Net Debt | -28,516,000USD | -390,000USD | -24,037,000USD | -32,747,000USD | 27,657,000USD | 26,520,000USD | -9,053,000USD | -10,271,000USD |
| Short Term Debt | 746,000USD | 13,605,000USD | 700,000USD | 297,000USD | 41,944,000USD | 35,513,000USD | 130,000USD | — |
| Short Long Term Debt Total | 1,631,000USD | 45,939,000USD | 45,510,000USD | 1,526,000USD | 43,409,000USD | 37,206,000USD | 188,000USD | — |
| Net Receivables | 5,397,000USD | 77,000USD | 4,416,000USD | 487,000USD | 0USD | — | — | — |
| Inventory | 2,236,000USD | 2,463,000USD | 1,022,000USD | -487,000USD | — | — | — | — |
| Accounts Payable | 2,072,000USD | 1,896,000USD | 2,464,000USD | 507,000USD | 845,000USD | 348,000USD | 1,185,000USD | 960,000USD |
| Property Plant Equipment Net | 1,862,000USD | 2,579,000USD | 3,615,000USD | 5,330,000USD | 5,502,000USD | 4,938,000USD | 2,201,000USD | 255,000USD |
| Property Plant Equipment Gross | 2,912,000USD | 3,837,000USD | 4,789,000USD | 6,029,000USD | 5,756,000USD | 4,938,000USD | 2,201,000USD | 255,000USD |
| Common Stock Shares Outstanding | 10,652,367shares | 5,180,822shares | 4,534,245shares | 3,416,343shares | 2,704,446shares | 2,499,555shares | 2,489,788shares | 2,485,282shares |
| Non Current Assets Total | 4,592,000USD | 2,955,000USD | 4,067,000USD | 5,606,000USD | 5,797,000USD | 6,504,000USD | 3,441,000USD | 754,000USD |
| Non Current Liabilities Total | 5,951,000USD | 34,982,000USD | 44,810,000USD | 1,229,000USD | 1,465,000USD | 1,693,000USD | 58,000USD | 0USD |
| Non Current Liabilities Other | 5,066,000USD | — | — | 1,229,000USD | 1,465,000USD | 1,693,000USD | 58,000USD | — |
| Non Currrent Assets Other | 2,730,000USD | 376,000USD | 452,000USD | 276,000USD | 295,000USD | 1,566,000USD | 1,240,000USD | 499,000USD |
| Net Working Capital | 26,102,000USD | 22,167,000USD | 60,506,000USD | 35,656,000USD | 28,273,000USD | 28,175,000USD | 61,632,000USD | 88,675,000USD |
| Unclassified Equity | 349,652,000USD | 297,149,000USD | 250,203,000USD | 203,478,000USD | 171,594,000USD | 136,865,000USD | 126,181,000USD | 122,523,000USD |
| Short Long Term Debt | — | 12,938,000USD | — | — | 41,693,000USD | 35,315,000USD | — | — |
| Long Term Debt | — | 30,983,000USD | 42,874,000USD | — | — | 35,315,000USD | — | — |
| Unclassified Current Liabilities | — | -12,938,000USD | — | — | -41,693,000USD | -35,315,000USD | — | — |
| Unclassified Non Current Liabilities | — | 3,999,000USD | 1,936,000USD | — | — | -41,268,000USD | — | — |
| Other Assets | — | — | 1USD | 276,000USD | 295,000USD | 1,566,000USD | 1,240,000USD | 499,000USD |
| Accumulated Other Comprehensive Income | — | — | 0USD | — | -29,000USD | 1,000USD | 20,000USD | -17,000USD |
| Short Term Investments | — | — | — | 0USD | 54,602,000USD | 54,784,000USD | 52,776,000USD | 79,538,000USD |
| Net Tangible Assets | — | — | — | 40,033,000USD | 32,605,000USD | 32,986,000USD | 65,015,000USD | 89,429,000USD |
| Deferred Long Term Liab | — | — | — | — | — | 100,000USD | — | — |
| Other Liab | — | — | — | — | — | 5,853,000USD | — | — |
| Unclassified Non Current Assets | — | — | — | — | — | -1,566,000USD | -1,240,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -9,682,000USD | -8,074,000USD | -274,000USD | 204,000USD | -9,742,000USD | -16,202,000USD | -22,860,000USD | -17,186,000USD |
| Depreciation | 194,000USD | 174,000USD | 184,000USD | 118,000USD | 208,000USD | 253,000USD | 342,000USD | 334,000USD |
| Stock Based Compensation | 897,000USD | 686,000USD | 718,000USD | 888,000USD | 1,026,000USD | 756,000USD | 2,108,000USD | 2,228,000USD |
| Other Non Cash Items | 2,345,000USD | 615,000USD | 1,124,000USD | 353,000USD | 417,000USD | 3,220,000USD | 832,000USD | 657,000USD |
| Change To Account Receivables | -2,416,000USD | 1,932,000USD | 10,042,000USD | -11,718,000USD | -5,559,000USD | -146,000USD | 10,277,000USD | -2,615,000USD |
| Change To Inventory | 262,000USD | -159,000USD | 218,000USD | -59,000USD | 0USD | — | 0USD | — |
| Change In Working Capital | -2,020,000USD | 2,008,000USD | 7,933,000USD | -11,607,000USD | -4,586,000USD | -4,091,000USD | 11,020,000USD | -2,391,000USD |
| Total Cash From Operating Activities | -9,163,000USD | -4,591,000USD | 9,685,000USD | -10,044,000USD | -12,677,000USD | -16,064,000USD | -8,558,000USD | -16,358,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | -16,000USD | -11,000USD |
| Free Cash Flow | -9,163,000USD | -4,591,000USD | 9,685,000USD | -10,044,000USD | -12,677,000USD | -16,064,000USD | -8,574,000USD | -16,369,000USD |
| Net Borrowings | -111,000USD | -36,006,000USD | -3,984,000USD | -4,155,000USD | -4,057,000USD | -1,514,000USD | -217,000USD | — |
| Total Cash From Financing Activities | -120,000USD | 13,641,000USD | -3,984,000USD | -4,155,000USD | -4,057,000USD | 39,426,000USD | -397,000USD | -640,000USD |
| Change In Cash | -9,547,000USD | 9,050,000USD | 5,701,000USD | -14,199,000USD | -16,734,000USD | 23,370,000USD | -8,971,000USD | -17,009,000USD |
| Begin Period Cash Flow | 30,147,000USD | 21,097,000USD | 15,396,000USD | 29,595,000USD | 46,329,000USD | 22,959,000USD | 31,930,000USD | 48,939,000USD |
| End Period Cash Flow | 20,600,000USD | 30,147,000USD | 21,097,000USD | 15,396,000USD | 29,595,000USD | 46,329,000USD | 22,959,000USD | 31,930,000USD |
| Other Cashflows From Financing Activities | -120,000USD | -420,000USD | -3,984,000USD | — | -3,959,000USD | 1,303,000USD | 662,000USD | -613,000USD |
| Unclassified Financing Cash Flow | — | 50,067,000USD | 3,984,000USD | — | 3,959,000USD | — | — | — |
| Investments | — | — | 0USD | — | — | 8,000USD | -16,000USD | -11,000USD |
| Total Cashflows From Investing Activities | — | — | — | — | — | 8,000USD | -16,000USD | -11,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | 39,637,000USD | 0USD | 0USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | 8,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -17,886,000USD | -76,579,000USD | -66,995,000USD | -24,487,000USD | -35,080,000USD | -42,694,000USD | -28,207,000USD | -20,648,000USD |
| Depreciation | 429,000USD | 1,269,000USD | 836,000USD | 718,000USD | 472,000USD | 229,000USD | 257,199USD | 20,000USD |
| Stock Based Compensation | 3,318,000USD | 7,164,000USD | 14,376,000USD | 4,985,000USD | 6,053,000USD | 9,821,000USD | 3,333,000USD | 2,251,000USD |
| Other Non Cash Items | 2,764,000USD | 5,192,000USD | 3,347,000USD | 1,934,000USD | 1,442,000USD | 802,000USD | 2,269,800USD | -435,000USD |
| Change To Account Receivables | -5,320,000USD | 4,339,000USD | -3,929,000USD | -487,000USD | -487,000USD | 410,000USD | -487,000USD | — |
| Change In Working Capital | -6,252,000USD | 2,027,000USD | 9,859,000USD | -1,800,000USD | -535,000USD | 1,635,000USD | -1,728,000USD | 938,000USD |
| Total Cash From Operating Activities | -17,627,000USD | -60,927,000USD | -38,577,000USD | -18,650,000USD | -27,582,000USD | -30,207,000USD | -27,408,000USD | -17,874,000USD |
| Capital Expenditures | 0USD | -27,000USD | -362,000USD | -302,000USD | -883,000USD | -1,470,000USD | -682,000USD | -774,000USD |
| Free Cash Flow | -17,627,000USD | -60,954,000USD | -38,939,000USD | -18,952,000USD | -28,465,000USD | -31,677,000USD | -28,090,000USD | -18,648,000USD |
| Net Borrowings | -48,202,000USD | -2,064,000USD | 44,082,000USD | -43,767,000USD | 4,975,000USD | 34,460,000USD | 34,460,000USD | 34,460,000USD |
| Total Cash From Financing Activities | 1,445,000USD | 37,728,000USD | 74,213,000USD | -16,870,000USD | 33,646,000USD | 35,232,000USD | 423,000USD | 99,376,000USD |
| Issuance Of Capital Stock | 50,067,000USD | 39,637,000USD | 30,301,000USD | 26,901,000USD | 28,118,000USD | 0USD | 0USD | 107,250,000USD |
| Change In Cash | -16,182,000USD | -23,218,000USD | 35,274,000USD | 18,521,000USD | 5,066,000USD | 1,445,000USD | -1,030,000USD | 1,608,000USD |
| Begin Period Cash Flow | 46,329,000USD | 69,547,000USD | 34,273,000USD | 15,752,000USD | 10,686,000USD | 9,241,000USD | 10,271,000USD | 8,663,000USD |
| End Period Cash Flow | 30,147,000USD | 46,329,000USD | 69,547,000USD | 34,273,000USD | 15,752,000USD | 10,686,000USD | 9,241,000USD | 10,271,000USD |
| Other Cashflows From Financing Activities | -420,000USD | 155,000USD | -169,000USD | -17,000USD | 558,000USD | 410,000USD | 423,000USD | 21,000,000USD |
| Investments | — | -19,000USD | 6,619,000USD | 54,523,000USD | 86,000USD | -1,889,000USD | 27,861,000USD | -79,120,000USD |
| Total Cashflows From Investing Activities | — | -19,000USD | -362,000USD | 54,041,000USD | -998,000USD | -3,580,000USD | 25,955,000USD | -79,894,000USD |
| Other Cashflows From Investing Activities | — | 8,000USD | — | -180,000USD | -201,000USD | -221,000USD | -1,224,000USD | -499,000USD |
| Unclassified Investing Cash Flow | — | — | -6,619,000USD | — | — | — | — | — |
| Change To Inventory | — | — | — | 487,000USD | — | — | — | — |
| Change To Liabilities | — | — | — | -593,000USD | 205,000USD | -338,000USD | 12,000USD | 1,861,000USD |
| Sale Purchase Of Stock | — | — | — | 26,901,000USD | 28,676,000USD | 453,000USD | 423,000USD | 78,376,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 18,521,000USD | 5,066,000USD | 1,445,000USD | -1,030,000USD | 1,608,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -3,332,999USD | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | -34,883,000USD | -34,460,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | License And Collaboration Revenue | 769,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product | 5,093,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | License And Collaboration Revenue | 733,000 | USD | 0001660334-26-000014 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 4,290,000 | USD | 0001660334-26-000014 |
| Q4 2025Quarterly · 2025-12-31 | Product | License And Collaboration Revenue | 1,370,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 3,722,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | License And Collaboration Revenue | 20,292,000 | USD | 0001660334-26-000008 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 15,285,000 | USD | 0001660334-26-000008 |
| Q3 2025Quarterly · 2025-09-30 | Product | License And Collaboration Revenue | 10,737,000 | USD | 0001660334-25-000006 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 3,607,000 | USD | 0001660334-25-000006 |
| Q2 2025Quarterly · 2025-06-30 | Product | License And Collaboration Revenue | 8,168,000 | USD | 0000950170-25-107358 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 4,534,000 | USD | 0000950170-25-107358 |
| Q1 2025Quarterly · 2025-03-31 | Product | License And Collaboration Revenue | 17,000 | USD | 0001660334-26-000014 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 3,422,000 | USD | 0001660334-26-000014 |
| FY 2024Yearly · 2024-12-31 | Product | License And Collaboration Revenue | 992,000 | USD | 0001660334-26-000008 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 6,574,000 | USD | 0001660334-26-000008 |
| Q2 2024Quarterly · 2024-06-30 | Product | License And Collaboration Revenue | 285,000 | USD | 0000950170-25-107358 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product | 4,892,000 | USD | 0000950170-25-107358 |
| Q1 2024Quarterly · 2024-03-31 | Product | Collaboration | 594,000 | USD | 0000950170-25-070452 |
| Q1 2024Quarterly · 2024-03-31 | Product | Product | 3,232,000 | USD | 0000950170-25-070452 |
| FY 2023Yearly · 2023-12-31 | Product | Collaboration | 466,000 | USD | 0000950170-25-037172 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 4,658,000 | USD | 0000950170-25-037172 |
| FY 2022Yearly · 2022-12-31 | Product | Collaboration | 9,032,000 | USD | 0000950170-24-022659 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 0 | USD | 0000950170-24-022659 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.